1. At a Glance
Exide Industries is India’s most recognisable battery brand and possibly the most conflicted largecap auto-ancillary today. On one hand, it reported Q3 FY26 revenue of ₹4,201 Cr (+4.6% YoY) and PAT of ₹195 Cr (+28% YoY). On the other hand, the stock is down ~16% in 3 months, ~11% over 1 year, and trades at ₹322 with a market cap of ₹27,353 Cr.
Valuation is not cheap comfort food anymore. At 32.8× trailing P/E, Exide is being valued closer to growth auto-ancillaries despite delivering 5-year sales CAGR of ~4% and ROE of just 5.7%. ROCE has steadily compressed from >20% a decade ago to ~9% today, reflecting maturity in the lead-acid business and capital intensity creeping in.
The only reason the market is still listening? Lithium-ion.
Exide has already invested ~₹4,202 Cr into Exide Energy Solutions Ltd (EESL), approved another ₹1,400 Cr, and is setting up a 12 GWh lithium-ion cell plant with commercial production expected in FY26. This is no pilot project. This is Exide betting multiple years of free cash flow on relevance.
Is this a visionary transition or a slow-burn ROCE destroyer? Read on.
2. Introduction
For decades, Exide was a textbook Indian industrial compounder — dominant distribution, stable replacement demand, high cash generation, boring but reliable. That era is over.
The Indian battery market is splitting into two worlds:
- Lead-acid: steady volumes, regulated recycling, low growth, price-competitive.
- Lithium-ion: high growth, brutal capex, uncertain margins, tech risk.
Exide sits awkwardly in between. Its core business still throws cash, but not enough growth to justify premium multiples. Meanwhile, lithium requires billions upfront, delivers losses initially, and punishes ROCE before rewarding scale players.
Management’s response has been aggressive:
